3SBio Prices IPO Above Range

3SBio Inc., a Shanghai, China-based developer of protein-based drugs, priced 7.7 million American depository shares at $16 per share ($12-$14 range), for an IPO take of approximately $123.2 million. It will trade on the Nasdaq under ticker symbol SSRX, while UBS served as lead underwriter. Shareholders include Walden International.